Abivax S.A. — Investor Relations & Filings
Abivax S.A. is a clinical-stage biotechnology company focused on developing therapeutics for chronic inflammatory diseases by harnessing the body's natural regulatory mechanisms. The company's core strategy revolves around modulating the immune response through microRNA (miRNA). Its lead drug candidate, obefazimod, is an investigational, orally administered small molecule with a novel mechanism of action. Obefazimod is designed to enhance the expression of miR-124, a key microRNA that regulates the inflammatory response. The primary development goal is the commercialization of obefazimod for the treatment of ulcerative colitis, with clinical programs also underway for Crohn's disease. The company is exploring obefazimod for other inflammatory indications and is investigating follow-on compounds from its proprietary chemical library.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 424B4 | 2023-10-23 | English | |
| Regulatory Filings 2023 | 2023-10-20 | English | |
| FWP | 2023-10-20 | English | |
| Regulatory Filings 2023 | 2023-10-20 | English | |
| Regulatory Filings 2023 | 2023-10-20 | English | |
| Regulatory Filings 2023 | 2023-10-19 | English |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2023
15 filings
| |||||
| 13630059 | 424B4 | 2023-10-23 | English | ||
| 13630062 | Regulatory Filings 2023 | 2023-10-20 | English | ||
| 13630061 | FWP | 2023-10-20 | English | ||
| 13630063 | Regulatory Filings 2023 | 2023-10-20 | English | ||
| 13630065 | Regulatory Filings 2023 | 2023-10-20 | English | ||
| 13630064 | Regulatory Filings 2023 | 2023-10-19 | English | ||
| 13630067 | 8-A12B | 2023-10-18 | English | ||
| 13630066 | Regulatory Filings 2023 | 2023-10-18 | English | ||
| 13630068 | Regulatory Filings 2023 | 2023-10-18 | English | ||
| 13630070 | Regulatory Filings 2023 | 2023-10-18 | English | ||
| 13630071 | F-1/A | 2023-10-18 | English | ||
| 13630069 | Regulatory Filings 2023 | 2023-10-17 | English | ||
| 13630074 | Regulatory Filings 2023 | 2023-10-16 | English | ||
| 13630073 | F-1/A | 2023-10-16 | English | ||
| 13630072 | Regulatory Filings 2023 | 2023-10-05 | English | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
Abivax S.A. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/30868/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=30868 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=30868 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=30868 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 30868}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Abivax S.A. (id: 30868)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.